![Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse](https://www.frontiersin.org/files/Articles/786451/fonc-12-786451-HTML-r1/image_m/fonc-12-786451-t001.jpg)
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig1_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download](https://images.slideplayer.com/26/8597741/slides/slide_4.jpg)
Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download
![Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.159/MediaObjects/41375_2013_Article_BFleu2012159_Fig1_HTML.jpg)
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
![The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c04d9260-a46d-4f38-8bc4-cad6a775e629/bjh_4867_f1.gif)
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
![t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.leu.2403091/MediaObjects/41375_2003_Article_BF2403091_Fig1_HTML.gif)
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia
![Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9019050/bin/41408_2022_662_Tab1_HTML.jpg)
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
![Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265017319432-gr1.jpg)
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
![PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience](https://i1.rgstatic.net/publication/337170779_Oncology_and_Radiotherapy_C_Outcome_of_stage_III-B_IgA-Kappa_FLC_MM_with_t414_karyotype_A_Nigerian_jehovah_witness_nine-year_experience/links/5dc99d36a6fdcc57504097f9/largepreview.png)
PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
![Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41385-022-00503-0/MediaObjects/41385_2022_503_Fig1_HTML.png)
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
![Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report](https://assets.cureus.com/uploads/figure/file/411818/234b6b10023911ed96697d4b21ba2f9a-Bello-blandina-spep-final-2.0.png)
Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report
![Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12185-020-03005-6/MediaObjects/12185_2020_3005_Fig1_HTML.png)
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma | Haematologica
![The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/95c2f91a-7269-4785-9561-f3cd80995d58/bjh_4867_f2.gif)
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
![Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22804-x/MediaObjects/41467_2021_22804_Fig1_HTML.png)